GIM
ELAN icon

Glenmede Investment Management’s Elanco Animal Health ELAN Stock Holding History

Glenmede Investment Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.47M Buy
73,180
+41,601
+132% +$697K 0.01% 614
2025
Q2 		$451K Buy
+31,579
New +$369K ﹤0.01% 959

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Glenmede Investment Management's ELAN Position: Q3 2025 in Review

Glenmede Investment Management increased its Elanco Animal Health (ELAN) stake by 132% in Q3 2025, buying an estimated $697K and bringing the position to 73,180 shares worth $1.47M. The position accounts for 0.01% of the portfolio, ranked #614.

Glenmede Investment Management first reported a position in ELAN in Q2 2025 and has held it in 2 quarters since. 410 funds tracked by Wall St. Rank hold ELAN as of Q3 2025.

  • Glenmede Investment Management held 73,180 shares of Elanco Animal Health worth $1.47M as of Q3 2025.
  • Glenmede Investment Management bought 41,601 Elanco Animal Health shares in Q3 2025, an estimated $697K.
  • Elanco Animal Health made up 0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #614 holding.
  • Glenmede Investment Management first reported a position in Elanco Animal Health in Q2 2025 and has held it in 2 quarters since.
  • 410 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.